BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9576748)

  • 1. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
    Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
    J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Alyonycheva TN; Safier LB; Hajjar KA; Posnett DN; Schoenborn MA; Schooley KA; Gayle RB; Maliszewski CR
    J Clin Invest; 1997 Mar; 99(6):1351-60. PubMed ID: 9077545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of extracellular ATP metabolism in regulation of platelet reactivity.
    Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
    J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment.
    Drosopoulos JH; Broekman MJ; Islam N; Maliszewski CR; Gayle RB; Marcus AJ
    Biochemistry; 2000 Jun; 39(23):6936-43. PubMed ID: 10841775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model.
    Buergler JM; Maliszewski CR; Broekman MJ; Kaluza GL; Schulz DG; Marcus AJ; Raizner AE; Kleiman NS; Ali NM
    J Thromb Thrombolysis; 2005 Apr; 19(2):115-22. PubMed ID: 16052302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
    Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
    J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
    Sashindranath M; Dwyer KM; Dezfouli S; Selan C; Crikis S; Lu B; Yuan Y; Hickey MJ; Peter K; Robson SC; Cowan PJ; Nandurkar HH
    Purinergic Signal; 2017 Jun; 13(2):259-265. PubMed ID: 28343356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
    Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro verification of antithrombotic effect of recombinant soluble nucleotide triphosphate diphosphohydrolase 1.
    Sampram ES; Ouriel K
    J Vasc Interv Radiol; 2004 Apr; 15(4):379-84. PubMed ID: 15064342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble apyrases release adp during ATP hydrolysis.
    Chen W; Guidotti G
    Biochem Biophys Res Commun; 2001 Mar; 282(1):90-5. PubMed ID: 11263976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
    Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
    J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
    Pulte D; Olson KE; Broekman MJ; Islam N; Ballard HS; Furman RR; Olson AE; Marcus AJ
    J Transl Med; 2007 May; 5():23. PubMed ID: 17480228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
    Hohmann JD; Wang X; Krajewski S; Selan C; Haller CA; Straub A; Chaikof EL; Nandurkar HH; Hagemeyer CE; Peter K
    Blood; 2013 Apr; 121(16):3067-75. PubMed ID: 23380744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
    Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease.
    El-Omar MM; Islam N; Broekman MJ; Drosopoulos JH; Roa DC; Lorin JD; Sedlis SP; Olson KE; Pulte ED; Marcus AJ
    Thromb Res; 2005; 116(3):199-206. PubMed ID: 15935828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional recombinant mosquito salivary apyrase: a potential therapeutic platelet aggregation inhibitor.
    Sun D; McNicol A; James AA; Peng Z
    Platelets; 2006 May; 17(3):178-84. PubMed ID: 16702045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution of His59 converts CD39 apyrase into an ADPase in a quaternary structure dependent manner.
    Grinthal A; Guidotti G
    Biochemistry; 2000 Jan; 39(1):9-16. PubMed ID: 10625474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.